Saturday, 23 October 2021

 

 

LATEST NEWS Rani Mukerji on 'Bunty Aur Babli 2': Vimmy is OG Babli 'Bigg Boss 15': Donal Bisht says ex-housemates pulled her down Saif Ali Khan puts on weight to play railway ticket collector in 'Bunty Aur Babli 2' KJo knows how to take a joke on himself Cinematographer who died on set of 'Rust' remembered as 'truly unique artist' 'Rust' shooting accident: Baldwin tweets his 'shock', union says prop gun had 'live round' Shaji Karun heads jury deciding India's Oscar entry; 'Sherni', 'Sardar Udham' lead race Censor Board wants 12 cuts in Madhur Bhandarkar's 'India Lockdown' Tinder rolls out new series 'The Swipe Ride' with Sara Ali Khan Prime Video drops engrossing trailer of courtroom drama 'Jai Bhim' Amit Sadh announces third season of 'Breathe: Into The Shadows' Aditya Chopra comes up with teaser of 'Bunty Aur Babli 2' Music composition of Mahesh Babu's 'Sarkaru Vaari Paata' wrapped up Sobering Effect: Gwyneth Paltrow 'barely had alcohol' since Covid diagnosis Bengali thriller 'F.I.R. No. 339/07/06' set to release on OTT Rohit Shetty praises Anil Charanjeett for 'Suraj Aur Saanjh' IANS Review: 'Bhavai': Pratik Gandhi shines as Ravan in an attempted eye-opener ‘Dramebaaz’ CM Channi did not even compensate farmer with whom he was photographed : Raghav Chadha 24X7 working Quick Response center will be set up to address problems faced by NRIs at Airport : Pargat Singh Plan and execute developmental projects with special emphasis on utility and longevity of projects : Rana Gurjit Singh Farmers To Get Treated Water For Irrigation : Rana Gurjeet Singh Lays Foundation

 

Serum Institute of India to apply for Oxford vaccine trials in India in a week

Web Admin

Web Admin

5 Dariya News

New Delhi , 20 Jul 2020

The Serum Institute of India (SII) will soon apply to the Indian regulator for the licensure trials of the AstraZeneca-Oxford Covid vaccine.Commenting on the AstraZeneca-Oxford  vaccine's results, Adar Poonawalla, CEO, Serum Institute of India, said, "The trials have shown promising results and we are extremely happy about it. We will be applying for the  licensure trials to the Indian regulator in a week's time. As soon as they grant us permission, we will begin with trials for the vaccine in India. In addition, we will soon start  manufacturing the vaccine in large volumes."Monday marked an important day in the battle against Covid as the first results of Oxford's Covid-19 vaccine showed that it is safe  and provokes an immune reaction in a person that lasts for almost two months.The researchers are indicating that the vaccine may be ready by year end. The results showed  that more than 91 per cent of volunteers injected produced an immune response against coronavirus which lasted for a month or more. The immune responses remained strong  for at least 56 days.Oxford University's vaccine, called AZD1222, is being manufactured by pharmaceutical major AstraZeneca and the UK government has ordered 100 million  doses ahead of time.As per the results, the vaccine boosted T cell and antibody immunity. The vaccine produced strong responses on both accounts, the study found, with T cell  immunity peaking after two weeks and then dropping slightly by day 56.Antibody immunity, on the other hand, peaked after four weeks and remained high by day 56, indicating  that it may well last for even longer.

 

Tags: Coronavirus , COVID 19 , Novel Coronavirus , India Fights Corona , Fight Against Corona , Stay Home Stay Safe , Stay Home , Corona Virus Updates , Coronavirus Epidemic , Coronavirus Pandemic , Corona virus threat , Corona Outbreak , Serum Institute of India , SII

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2021 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD